Cargando…
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine
BACKGROUND: Rizatriptan is an effective and fast acting drug for the acute treatment of migraine. Some nonsteroidal anti-inflammatory drugs (NSAID) have also demonstrated efficacy in treating migraine attacks. There is evidence that the combination of a triptan and a NSAID decreases migraine recurre...
Autores principales: | Krymchantowski, Abouch Valenty, Bigal, Marcelo Eduardo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC449711/ https://www.ncbi.nlm.nih.gov/pubmed/15222892 http://dx.doi.org/10.1186/1471-2377-4-10 |
Ejemplares similares
-
Rizatriptan in the treatment of migraine
por: Láinez, Miguel JA
Publicado: (2006) -
Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life
por: Amoozegar, Farnaz, et al.
Publicado: (2009) -
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine
por: Savi, Lidia, et al.
Publicado: (2010) -
Thermoreversible Biogels for Intranasal Delivery of Rizatriptan Benzoate
por: Chand, Renuka, et al.
Publicado: (2009) -
Frovatriptan and Rizatriptan Economic EVAluation: the FREEVA study
por: Lisotto, Carlo, et al.
Publicado: (2013)